Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
CGII Holdings (01940) receives approximately a 60.38% discount on the full purchase offer and will resume trading on March 16th.

WEIYE HOLDINGS (01571) plans to change its name to "Dingjisheng International Holdings Limited"

YAN TAT GROUP (01480) plans to invest 13.8 million yuan to purchase a number of PCB processing equipment.
CGII Holdings (01940) receives approximately a 60.38% discount on the full purchase offer and will resume trading on March 16th.
WEIYE HOLDINGS (01571) plans to change its name to "Dingjisheng International Holdings Limited"

YAN TAT GROUP (01480) plans to invest 13.8 million yuan to purchase a number of PCB processing equipment.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


